Cannabis, Pain Relief, Target Segments

Demand Brand acquires DMR and all of its MigraPure™ breakthrough Migraine therapy assets

The patented MigraPure™ products are a result of 15 years of research and development including 4 successful clinical studies. A MigraPure™ Hemp version will also be introduced in the near term. Migraines are an illness that plagues approximately 20% of all women, 10% of men and 10% of children and adolescents. The market is substantial and is expected to grow to $8.7 Billion by 2020.

DMAN is developing a wide variety of innovative products including gummies, liquid extracts and other Hemp + Healthy, CBD-infused edibles and Superfoods designed for men, women, children and pets. The Company will acquire DMR and the MigraPure™ assets with a combination of stock and cash and the transaction is expected to be completed within 30 days. Russ Mitchell CEO of DMR will be joining the Company and will manage the development, production and distribution of the DMR products and certain DMAN products in a wholly owned subsidiary.

Bruce Hannan, CEO of DMAN, said, “We believe that the MigraPure™ products are truly revolutionary and a great fit for the Company. The clinical studies have proven its effectiveness on this illness that so many suffer from and it is ready to go to market. Russ Mitchell is a respected and experienced inventor and distributor of homeopathic drugs and supplements and we are thrilled to have him on the team.”

Russ Mitchell, of DMR added, “I am excited to partner with Bruce and Demand Brands to launch these remarkable products along with other unique, scientifically validated hemp fortified treatments designed to help millions of people suffering from debilitating diseases.”

Read More on Yahoo Financial:

Click Here to Download the Press Release >>

Leave your thought here